(Q41984219)

14 October 2017

Alemtuzumab therapy for leukemic cutaneous T-cell lymphoma: diffuse erythema as a positive predictor of complete remission (English)

1 reference

14 October 2017

1 reference

Rei Watanabe

1

1 reference

14 October 2017

Jessica E Teague

2

1 reference

14 October 2017

David C Fisher

3

1 reference

14 October 2017

Thomas S Kupper

4

1 reference

14 October 2017

Rachael A Clark

5

1 reference

14 October 2017

language of work or name

English

0 references

publication date

1 July 2014

1 reference

14 October 2017

1 reference

14 October 2017

150

1 reference

14 October 2017

7

1 reference

14 October 2017

776-779

1 reference

Skin effector memory T cells do not recirculate and provide immune protection in alemtuzumab-treated CTCL patients.

14 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4092049

PubMed Central

reference URL

Sezary syndrome and mycosis fungoides arise from distinct T-cell subsets: a biologic rationale for their distinct clinical behaviors

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4092049

PubMed Central

reference URL

The vast majority of CLA+ T cells are resident in normal skin.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4092049

PubMed Central

reference URL

10.1001/JAMADERMATOL.2013.10099

18 August 2018

Identifiers

DOI

1 reference

14 October 2017

1 reference

14 October 2017

PubMed publication ID

24760312

1 reference